Strensiq

Active Ingredient(s): Asfotase Alfa
FDA Approved: * October 23, 2015
Pharm Company: * ALEXION PHARM

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Strensiq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Asfotase Alfa
  • Solution: 18mg/0.45ml, 28mg/0.7ml, 40mg/ml, 80mg/0.8ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Strensiq: (4 results)

Sorted by National Drug Code
  • 25682-010 Strensiq 18 mg/.45ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-013 Strensiq 28 mg/.7ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-016 Strensiq 40 mg/ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-019 Strensiq 80 mg/.8ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.

Other drugs which contain Asfotase Alfa or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 3 June 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA